Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact Evaluation of the Nigeria Result-Based Financing Project

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03890653
Recruitment Status : Active, not recruiting
First Posted : March 26, 2019
Last Update Posted : March 26, 2019
Sponsor:
Information provided by (Responsible Party):
World Bank

Brief Summary:

The World Bank and the government of Nigeria are implementing a results-based financing (RBF) project for the states of Nasarawa, Adamawa, and Ondo. This project provides incentives for improving performance at critical levels within the Nigerian health system and aims to address some of these challenges. The primary goal of the impact evaluation of this project is to determine if providing financial incentives linked directly to performance increases the quantity and quality of maternal and child health (MCH) services.

In each of the three selected States,the project finances the following interventions:

  1. Performance incentives to State Government and Local Government (LGA) agencies that are triggered by Disbursement Linked Indicators (DLIs) that reflect strengthened supervision and enhanced operational support for improving health systems performance. These performance incentives would be paid out on an annual basis.
  2. In half of the LGAs in each state, one facility per ward will receive Performance-Based Financing (PBF) wherein payments are made directly to individual health facilities based on the quantity and quality of a set of pre-defined services provided by each facility. These performance incentives would be paid out on a quarterly basis.
  3. In the other half of the LGAs in each state one facility per ward will receive Decentralized Facility Financing (DFF) or equivalent financing that is not be linked to any service delivery targets. These payments would be made on a quarterly basis.

The evaluation of the PBF arm, which consists of making payments to health facilities conditional on performance, but within an environment of comparable levels of overall financing, will rely on experimental assignment. The effect of the PBF intervention will be identified by comparing outcomes in the LGAs receiving PBF versus those receiving DFF in the three project states. In each of these three States, the LGAs will be randomly assigned to either the PBF package or to the DFF package.


Condition or disease Intervention/treatment Phase
Maternal Care Patterns Behavioral: Performance-Based Financing Behavioral: Decentralized Facility Financing Not Applicable

Detailed Description:
A detailed description can be found in the attached project concept note.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 74 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Impact Evaluation of the Nigeria State Health Program Investment Credit (NSHPIC)
Actual Study Start Date : August 20, 2013
Actual Primary Completion Date : September 30, 2017
Estimated Study Completion Date : December 15, 2019

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Performance-Based Financing
At least one primary healthcare centre per ward and one General Hospital per selected LGA (in 50% of LGAs in each of the 3 states) and one secondary hospital per State will be contracted by the State Primary Health Care Development Agency ) , to deliver specified services at an agreed price. Selection of which services to focus on is based on priorities identified by the Federal Government of Nigeria and the states in 2010-2015. Initial prices for each service were based on shadow prices of providing the service and have been adjusted based on implementation experience.
Behavioral: Performance-Based Financing
Incentive-based payments

Experimental: Decentralized Facility Financing
In the other half of the LGA's in each treated state, at least one facility per ward will receive Decentralized Facility Financing (DFF) or equivalent financing that is not be linked to any service delivery targets. These payments would be made on a quarterly basis.
Behavioral: Decentralized Facility Financing
Financing not linked to service delivery.

No Intervention: Control
This is a pure control arm with no additional interventions.



Primary Outcome Measures :
  1. Utilization of priority maternal and child health services [ Time Frame: Each health facility assessed over a period of two days. ]
    The utilization of priority MCH services, as defined by the quantitative checklist used by the project to measure and reward facility performance.


Secondary Outcome Measures :
  1. Utilization of priority maternal and child health services, particularly by the poor [ Time Frame: Each health facility assessed over a period of two days. ]
    The utilization of priority MCH services, as defined by the quantitative checklist used by the project to measure and reward facility performance, by poor households.

  2. Aggregated Provider Performance through Direct Clinical Observation [ Time Frame: Each health provider assessed over a period of one day. ]
    We use data on direct clinical observations of labor and delivery to construct an aggregate measure of provider performance.

  3. Aggregate Structural and Process Quality Index [ Time Frame: Each health facility assessed over a period of two days. ]
    The quantitative checklist used in the government program is replicated to a large degree in the impact evaluation survey. We construct independent observations on aggregate structural and process quality measures in the same fashion as the program has constructed and rewarded.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. All health facility staff in the states of Nasarawa, Adamawa and Ondo attending to maternity patients in the study period.
  2. Selected mothers recently utilizing the same facilities if consent is provided.

Exclusion Criteria:

1. None.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03890653


Sponsors and Collaborators
World Bank
Investigators
Layout table for investigator information
Principal Investigator: Eeshani Kandpal, PhD World Bank

Study Data/Documents: Project Concept Note  This link exits the ClinicalTrials.gov site
This is the initial project description document.

Layout table for additonal information
Responsible Party: World Bank
ClinicalTrials.gov Identifier: NCT03890653     History of Changes
Other Study ID Numbers: P128175
First Posted: March 26, 2019    Key Record Dates
Last Update Posted: March 26, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No